Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Cladribine tablets bulk supplier for pharma manufacturers

Cladribine Tablets 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg

Reference Brands: Mavenclad(US & EU)

Category: Multiple sclerosis

Cladribine tablets inhibit DNA synthesis by targeting lymphocytes, reducing inflammation and immune attack in multiple sclerosis. It decreases relapse rates, slows disease progression, and reduces lesion activity. Benefits include oral convenience, long-lasting effects, fewer doses needed, and improved quality of life for relapsing MS patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Cladribine tablets, marketed as Mavenclad, are approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis (MS). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures compliance with regional safety, efficacy, and quality standards. 

Cladribine Tablets — third party manufacturing & bulk supply

Cladribine Tablets 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Cladribine Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cladribine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Cladribine Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Cladribine tablets is listed as Tablet in 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cladribine tablets is referenced against Mavenclad(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Cladribine tablets is catalogued under Multiple sclerosis on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Lamotriginevdispersible Tablets

Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Form: Tablets(IR & ER)

Reference Brands: Lamictal, Lamictal XR(EU & US)

View Details
Dalfampridine

Strength:
10 mg

Form: Extended-Release tablets (XR)

Reference Brands: Ampyra(US)

View Details
Tizanidine Tablets/Capsules

Strength:
2 mg and 4 mg

Form: Oral Capsules/Tablets

Reference Brands: Zanaflex (US)

View Details
Baclofen Tablets:

Strength:
10 mg and 20 mg

Form: Tablet

Reference Brands: Lioresal, Gablofen(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.